BIRT 377

Also Known As:

(R)-5-(4-bromophenyl)-3-(3,5-dichlorophenyl)-1,5-dimethyl-imidazolidine-2,4-dione; (R)-5-(4-bromophenyl)-3-(3,5-dichlorophenyl)-1,5-dimethylimidazolidine-2,4-dione

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Imidazoles: 150
      - Imidazolidines: 39
        BIRT 377: 1

Experts

1.	Desai, S: 1 article (10/2001)
2.	Fogal, S: 1 article (10/2001)
3.	Haynes, N A: 1 article (10/2001)
4.	Nabozny, G H: 1 article (10/2001)
5.	Panzenbeck, M: 1 article (10/2001)
6.	Reilly, P L: 1 article (10/2001)
7.	Souza, D: 1 article (10/2001)
8.	Winquist, R J: 1 article (10/2001)

Related Diseases

1.	Hypersensitivity (Allergy) 10/19/2001 - "The BIRT 377 analog, BIX 642, inhibited the cellular infiltrate and increase in skin thickness associated with the delayed-type hypersensitivity reaction in previously immunized squirrel monkeys challenged with antigen. "

Related Drugs and Biologics

1.	Antigens